Fujifilm's new inline Raman system aims to tighten bioprocess control

Byline: Ad-hoc-news | June 17, 2026

Fujifilm and HORIBA have introduced a high-sensitivity inline Raman measurement system for real-time bioprocess monitoring. The launch targets users who need clearer control during cell culture and purification.

Why this matters now

The new system arrives as biomanufacturing keeps pushing for tighter process visibility. Inline measurement can reduce delays that come with offline sampling and lab turnaround.

For teams running sensitive production lines, that can mean faster decisions and fewer wasted batches. It also fits a broader industry move toward continuous, data-driven quality control.

Built for the pressure of live production

Raman measurement is useful because it can track chemical composition without pulling a sample out of the line. In practice, that helps operators watch conditions as they change, instead of reacting after the fact.

Fujifilm said the system is designed for high sensitivity, which is important when signals are weak or the process window is narrow. That makes it especially relevant for complex cell culture and purification workflows.

Fujifilm Holdings Corp. market context

The parent company is Fujifilm Holdings Corp., ticker TSE:4901, ISIN JP3814000000. The announcement adds another piece to Fujifilm's life sciences and advanced manufacturing push, a segment investors have watched for growth beyond imaging.

For the market, the news is less about consumer hardware and more about recurring industrial value. Tools that improve process control can become sticky once they are built into regulated production environments.

Editorial note: This article may contain affiliate links. The editorial content remains independent.